title: [Natalizumab and atypical naevi: Comments on the pharmacovigilance note by J.-L. Schmutz et al].
authors.forename: O
authors.initials: O
authors.lastname: Yaldizli
authors.forename: P
authors.initials: P
authors.lastname: Baumberger
authors.forename: N
authors.initials: N
authors.lastname: Putzki
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008545:Melanoma / Q000188:drug therapy; D000069442:Natalizumab; D009506:Nevus / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab